CTI BioPharma
CTIC
#5205
Rank
A$1.90 B
Marketcap
$14.44
Share price
0.00%
Change (1 day)
35.55%
Change (1 year)

Revenue for CTI BioPharma (CTIC)

Revenue in 2023 (TTM): A$0.11 Billion

According to CTI BioPharma 's latest financial reports the company's current revenue (TTM ) is A$0.12 Billion. In 2022 the company made a revenue of A$79.27 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CTI BioPharma from 1997 to 2023

20002005201020152020$20M$40M$60M$80M$0.1B$0.12B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2023 (TTM) A$0.11 B42.3%
2022 A$79.27 M
2021 N/A
2020 N/A-100%
2019 A$4.77 M-87.02%
2018 A$36.79 M14.24%
2017 A$32.2 M-59.56%
2016 A$79.63 M259.99%
2015 A$22.12 M-69.86%
2014 A$73.4 M88.82%
2013 A$38.87 M
2012 N/A
2011 N/A-100%
2010 A$0.31 M252.64%
2009 A$0.08 M-99.45%
2008 A$16.2 M11054.78%
2007 A$0.14 M43.14%
2006 A$0.1 M-99.54%
2005 A$21.99 M-42.49%
2004 A$38.24 M14.78%
2003 A$33.31 M11.1%
2002 A$29.98 M145.43%
2001 A$12.21 M1260.8%
2000 A$0.89 M96.68%
1999 A$0.45 M-97.88%
1998 A$21.55 M19.03%
1997 A$18.11 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$53.11 B 44,013.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$76.74 B 63,646.39%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.73 B 5,497.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.42 B 16,867.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$71.57 B 59,347.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.28 B 21,733.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$82.18 B 68,162.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland